Fingerprint
Dive into the research topics of 'Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis
E. R. Dorsey, J. P. Thompson, K. Noyes, A. W. Dick, R. G. Holloway, S. R. Schwid
Research output: Contribution to journal › Article › peer-review
20
Scopus
citations